Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/29444
Title: Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study
Authors: Silva, C. A. A.
Hilario, M. O.
Febronio, M. V.
Oliveira, S. K.
Terreri, M. T.
Sacchetti, S. B.
Sztajnbok, F. R.
Marini, R.
Quintero, M. V.
Bica, B. E.
Pereira, R. M.
Bonfa, E.
Ferriani, V. P.
Robazzi, T. C.
Magalhaes, C. S.
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Universidade Federal do Rio de Janeiro (UFRJ)
Santa Casa São Paulo
Universidade do Estado do Rio de Janeiro (UERJ)
Universidade Estadual de Campinas (UNICAMP)
Santa Casa Belo Horizonte
Hosp Sao Rafael Bahia
Keywords: adolescent
amenorrhea
cyclophosphamide
gonadal function
juvenile systemic lupus erythematosus
Issue Date: 1-Jan-2007
Publisher: Sage Publications Ltd
Citation: Lupus. London: Sage Publications Ltd, v. 16, n. 7, p. 531-536, 2007.
Abstract: We evaluated the prevalence and clinical associations of amenorrhea in 298 female juvenile systemic lupus erythematosus (JSLE) patients (ACR criteria) followed in 12 Brazilian Paediatric Rheumatology centres. Amenorrhea was observed in 35 patients (11.7%) with a mean duration of 7.2 +/- 3.6 months. the hormones were performed in 32/35 patients and none of them had FSH and LH levels above and estradiol below the normal range according to pubertal changes. JSLE patients with amenorrhea were younger (15.04 +/- 2.5 versus 17.8 +/- 3.1 years; P = 0.001), and had a shorter period of time between menarche and current age (3.4 +/- 2.9 versus 6.7 +/- 5.4 years; P = 0.001). Interestingly, the frequency, cumulative dose, number of pulses and duration of intravenous cyclophosphamide treatment were alike in patients with and without amenorrhea (P > 0.05). in contrast, patients with amenorrhea had significantly higher SLEDAI (P = 0.01) and SLICC/ACR-DI (P = 0.024) scores compared to those without this condition. Independent risk factors identified by multivariate analysis were higher SLEDAI (OR=1.059; CI=1.004-1.116; P=0.034) and SLICC/ACR-DI (OR=2.125; IC = 1.373-3.291; P = 0.001) scores. Our data suggest that in spite of imummosuppressive therapy, JSLE patients have an adequate ovarian follicular reserve and amenorrhea is particularly associated with disease activity and damage.
URI: http://repositorio.unifesp.br/handle/11600/29444
ISSN: 0961-2033
Other Identifiers: http://dx.doi.org/10.1177/0961203307079300
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.